CITI Good Clinical Practice Course Exam | Verified Exam Questions and
Answers | Latest Updated Study Material 2026
Question:
CITI Good Clinical Practice Course Exam |Comprehensive
Bioavailability
Answer:
the degree to which, or the rate at which, a
medication or other substance is absorbed or becomes available at the targeted place in the body
Question:
Clinical Trial (aka Clinical Investigation or Clinical Study)
Answer:
is
any investigation in human subjects intended to discover or verify the clinical, pharmacological,
and/or other pharmacodynamic effects of an investigational product(s), whether approved for
marketing or not, and/or to identify any adverse reactions to an investigational product(s), and/or
to study absorption, distribution, metabolism, and excretion of an investigational product(s) with
the object of ascertaining its efficacy and/or safety
Question:
Controlled
Answer:
means that subjects are split into at least two groups:
those receiving the experimental agent and those receiving a standard treatment for the condition
(an active control), no treatment, or a placebo. If subjects are assigned randomly into these
groups, the study is a randomized controlled trial
Question:
Good Clinical Practice (GCP)
Answer:
a standard for the design, conduct,
performance, monitoring, auditing, recording, analyses, and reporting of clinical trials
, Question:
Investigator
Answer:
the individual who actually conducts the trial
Question:
Pharmacogenomics
Answer:
describes the effects of the agent while in
the body
Question:
Pharmacodynamics
Answer:
the use of genetic information to predict
whether a drug will help make a patient well or ill
Question:
Pharmacokinetics
Answer:
describes how the agent moves through and is
excreted from the body
Question:
Placebo
Answer:
an inactive substance that looks the same as, and is
administered in the same way as, a drug in a clinical trial
Question:
Subinvestigator
Answer:
an individual who is a member of the clinical
trial team designated and supervised by the investigator to perform critical trial-related
procedures and/or to make important trial-related decisions (for example, associates, residents,
research fellows)
Answers | Latest Updated Study Material 2026
Question:
CITI Good Clinical Practice Course Exam |Comprehensive
Bioavailability
Answer:
the degree to which, or the rate at which, a
medication or other substance is absorbed or becomes available at the targeted place in the body
Question:
Clinical Trial (aka Clinical Investigation or Clinical Study)
Answer:
is
any investigation in human subjects intended to discover or verify the clinical, pharmacological,
and/or other pharmacodynamic effects of an investigational product(s), whether approved for
marketing or not, and/or to identify any adverse reactions to an investigational product(s), and/or
to study absorption, distribution, metabolism, and excretion of an investigational product(s) with
the object of ascertaining its efficacy and/or safety
Question:
Controlled
Answer:
means that subjects are split into at least two groups:
those receiving the experimental agent and those receiving a standard treatment for the condition
(an active control), no treatment, or a placebo. If subjects are assigned randomly into these
groups, the study is a randomized controlled trial
Question:
Good Clinical Practice (GCP)
Answer:
a standard for the design, conduct,
performance, monitoring, auditing, recording, analyses, and reporting of clinical trials
, Question:
Investigator
Answer:
the individual who actually conducts the trial
Question:
Pharmacogenomics
Answer:
describes the effects of the agent while in
the body
Question:
Pharmacodynamics
Answer:
the use of genetic information to predict
whether a drug will help make a patient well or ill
Question:
Pharmacokinetics
Answer:
describes how the agent moves through and is
excreted from the body
Question:
Placebo
Answer:
an inactive substance that looks the same as, and is
administered in the same way as, a drug in a clinical trial
Question:
Subinvestigator
Answer:
an individual who is a member of the clinical
trial team designated and supervised by the investigator to perform critical trial-related
procedures and/or to make important trial-related decisions (for example, associates, residents,
research fellows)
